Alzheimer's Drugs: Little Benefit, Big Risks
Anti-amyloid Alzheimer's drugs show limited benefit & increased risks of brain swelling/bleeding. Re-evaluating treatment efficacy is crucial.
04 May 2026
Blood Test Identifies Early Dementia Markers
New blood test uses gut microbiome markers for early dementia detection, achieving over 80% accuracy in identifying mild cognitive impairment.
04 May 2026
Blood Test Identifies Alzheimer's Biomarker Years Before Scans
New blood test for pTau217 detects Alzheimer's indicators years before symptoms, aiding early risk identification and clinical trial design.
02 May 2026
